• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5岁以下急性下呼吸道感染儿童呼吸道合胞病毒(RSV)感染的危险因素。

Risk factors for respiratory syncytial virus (RSV) infection in children under 5 years old with acute lower respiratory tract infection.

作者信息

Srisingh Klaita, Khongthongprasert Sawangwong, Jaturabundit Tarit, Soponwaree Nattacha, Klangsombat Kittiporn, Sriwad Chadawan, Oilmungmool Nongluk, Phuaksaman Chutima, Lawanaskol Suppachai

机构信息

Division of Pulmonology, Department of Pediatrics, Faculty of Medicine, Naresuan University Hospital, Naresuan University, Phitsanulok, Thailand.

Department of Radiology, Faculty of Medicine, Naresuan University Hospital, Naresuan University, Phitsanulok, Thailand.

出版信息

J Thorac Dis. 2025 Jul 31;17(7):4565-4575. doi: 10.21037/jtd-2024-2170. Epub 2025 Jul 24.

DOI:10.21037/jtd-2024-2170
PMID:40809250
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12340257/
Abstract

BACKGROUND

Respiratory syncytial virus (RSV) infection is a significant burden for children under 5 years of age. While RSV is a common cause of acute lower respiratory tract infection (ALRTI), routine confirmatory testing is not widely practiced. Identifying risk factors for RSV infection can help inform clinical decision-making and guide appropriate management in emergency departments. The objective of this study is to determine the risk factors associated with RSV infection in children hospitalized with ALRTI.

METHODS

A retrospective case-control study was conducted among pediatric patients under 5 years of age diagnosed with ALRTI at Naresuan University Hospital between January 2018 and December 2020. Data were extracted from electronic medical records. RSV diagnoses were confirmed using a rapid RSV antigen test. Potential risk factors-including prematurity, family history of atopic disease, past respiratory illness, history of ALRTI contact, and underlying disease-were analyzed using a multivariable logistic model in Stata version 17.0.

RESULTS

Among 3,579 children hospitalized with ALRTI, 459 (13%) were diagnosed with RSV infection. Peaks in RSV-ALRTI were observed in September, October, and November across 2018-2020. Significant risk factors identified through multivariable logistic regression analysis included the rainy season [odds ratio (OR) =15.51; 95% confidence interval (CI): 1.74-138.42; P=0.01], daycare attendance (OR =3.00; 95% CI: 1.27-7.10; P=0.01), lung crepitations (OR =2.60; 95% CI: 1.23-5.50; P=0.01), and oxygen supplementation (OR =2.38; 95% CI: 1.07-5.30; P=0.03).

CONCLUSIONS

This study highlights the significant clinical burden of RSV in ALRTI, with RSV-ALRTI accounting for 13% of all ALRTI cases. Notably, RSV-ALRTI cases peaked during the rainy season, specifically in September, October, and November. The identified risk factors for RSV-ALRTI include the rainy season, daycare attendance, lung crepitations, and the need for oxygen supplementation. These findings underscore the importance of early identification and management of high-risk patients, particularly during peak seasonal periods. Clinically, these risk factors can help guide targeted prevention and treatment strategies, improving patient outcomes and optimizing resource allocation in healthcare settings.

摘要

背景

呼吸道合胞病毒(RSV)感染是5岁以下儿童的一项重大负担。虽然RSV是急性下呼吸道感染(ALRTI)的常见病因,但常规确诊检测并未广泛开展。识别RSV感染的风险因素有助于为临床决策提供依据,并指导急诊科的适当管理。本研究的目的是确定因ALRTI住院的儿童中与RSV感染相关的风险因素。

方法

对2018年1月至2020年12月期间在那黎宣大学医院被诊断为ALRTI的5岁以下儿科患者进行了一项回顾性病例对照研究。数据从电子病历中提取。使用快速RSV抗原检测确诊RSV感染。潜在风险因素,包括早产、特应性疾病家族史、既往呼吸道疾病、ALRTI接触史和基础疾病,在Stata 17.0版本中使用多变量逻辑模型进行分析。

结果

在3579例因ALRTI住院的儿童中,459例(13%)被诊断为RSV感染。在2018 - 2020年期间,9月、10月和11月观察到RSV-ALRTI病例数达到峰值。通过多变量逻辑回归分析确定的显著风险因素包括雨季(比值比[OR]=15.51;95%置信区间[CI]:1.74 - 138.42;P = 0.01)、日托机构入托(OR = 3.00;95% CI:1.27 - 7.10;P = 0.01)、肺部啰音(OR = 2.60;95% CI:1.23 - 5.50;P = 0.01)和吸氧(OR = 2.38;95% CI:1.07 - 5.30;P = 0.03)。

结论

本研究突出了RSV在ALRTI中的重大临床负担,RSV-ALRTI占所有ALRTI病例的13%。值得注意的是,RSV-ALRTI病例在雨季达到峰值,特别是在9月、10月和11月。确定的RSV-ALRTI风险因素包括雨季、日托机构入托、肺部啰音和吸氧需求。这些发现强调了早期识别和管理高危患者的重要性,特别是在季节性高峰期。临床上,这些风险因素有助于指导有针对性的预防和治疗策略,改善患者预后并优化医疗机构的资源分配。

相似文献

1
Risk factors for respiratory syncytial virus (RSV) infection in children under 5 years old with acute lower respiratory tract infection.5岁以下急性下呼吸道感染儿童呼吸道合胞病毒(RSV)感染的危险因素。
J Thorac Dis. 2025 Jul 31;17(7):4565-4575. doi: 10.21037/jtd-2024-2170. Epub 2025 Jul 24.
2
Risk factors for severe lower respiratory tract infection among children under 5 years of age hospitalized with respiratory syncytial virus.呼吸道合胞病毒住院的5岁以下儿童严重下呼吸道感染的危险因素。
Eur J Clin Microbiol Infect Dis. 2025 Jun 25. doi: 10.1007/s10096-025-05191-9.
3
Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses.帕利珠单抗预防高危婴儿和幼儿呼吸道合胞病毒(RSV)毛细支气管炎的免疫预防作用:亚组分析的系统评价和额外的经济建模。
Health Technol Assess. 2011 Jan;15(5):iii-iv, 1-124. doi: 10.3310/hta15050.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
A systematic review of compliance with palivizumab administration for RSV immunoprophylaxis.对帕利珠单抗用于呼吸道合胞病毒免疫预防给药依从性的系统评价。
J Manag Care Pharm. 2010 Jan-Feb;16(1):46-58. doi: 10.18553/jmcp.2010.16.1.46.
6
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒(RSV)感染。
Cochrane Database Syst Rev. 2021 Nov 16;11(11):CD013757. doi: 10.1002/14651858.CD013757.pub2.
7
Immunoglobulin treatment for hospitalised infants and young children with respiratory syncytial virus infection.免疫球蛋白治疗住院婴儿和幼儿呼吸道合胞病毒感染。
Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD009417. doi: 10.1002/14651858.CD009417.pub3.
8
Burden of Respiratory Syncytial Virus Disease in Adults with Asthma and Chronic Obstructive Pulmonary Disease: A Systematic Literature Review.哮喘和慢性阻塞性肺疾病成人患者呼吸道合胞病毒病负担:一项系统文献综述
Curr Allergy Asthma Rep. 2025 Feb 25;25(1):14. doi: 10.1007/s11882-025-01194-w.
9
Palivizumab for preventing severe respiratory syncytial virus (RSV) infection in children.帕利珠单抗预防儿童严重呼吸道合胞病毒(RSV)感染。
Cochrane Database Syst Rev. 2025 Jul 23;7(7):CD013757. doi: 10.1002/14651858.CD013757.pub3.
10
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024.2023 - 2024年呼吸道合胞病毒疾病负担及尼塞韦单抗在幼儿中的有效性
JAMA Pediatr. 2025 Feb 1;179(2):179-187. doi: 10.1001/jamapediatrics.2024.5572.

本文引用的文献

1
The Impact of COVID-19 Pandemic on Respiratory Syncytial Virus Infection in Children.COVID-19 大流行对儿童呼吸道合胞病毒感染的影响。
Pulm Med. 2024 Oct 18;2024:2131098. doi: 10.1155/2024/2131098. eCollection 2024.
2
Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study.在 COVID-19 大流行期间呼吸道合胞病毒的季节性和严重程度:一项动态队列研究。
Int J Infect Dis. 2024 Nov;148:107231. doi: 10.1016/j.ijid.2024.107231. Epub 2024 Sep 1.
3
Risk factors for respiratory syncytial virus-associated acute lower respiratory infection in children under 5 years: An updated systematic review and meta-analysis.
5 岁以下儿童呼吸道合胞病毒相关性急性下呼吸道感染的危险因素:更新的系统评价和荟萃分析。
Int J Infect Dis. 2024 Sep;146:107125. doi: 10.1016/j.ijid.2024.107125. Epub 2024 Jun 28.
4
Rhinovirus-induced wheeze was associated with asthma development in predisposed children.鼻病毒诱发的喘息与易患儿童的哮喘发展有关。
Acta Paediatr. 2024 Jun;113(6):1376-1384. doi: 10.1111/apa.17158. Epub 2024 Feb 19.
5
Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children.住院儿童严重呼吸道合胞病毒感染的危险因素。
Pediatr Infect Dis J. 2024 Jun 1;43(6):487-492. doi: 10.1097/INF.0000000000004270. Epub 2024 Jan 31.
6
Risk factors for severe respiratory syncytial virus infection during the first year of life: development and validation of a clinical prediction model.生命第一年严重呼吸道合胞病毒感染的危险因素:临床预测模型的建立和验证。
Lancet Digit Health. 2023 Nov;5(11):e821-e830. doi: 10.1016/S2589-7500(23)00175-9.
7
Epidemiology and risk factors of respiratory syncytial virus associated acute respiratory tract infection in hospitalized children younger than 5 years from Sri Lanka.斯里兰卡5岁以下住院儿童呼吸道合胞病毒相关急性呼吸道感染的流行病学及危险因素
Front Microbiol. 2023 Jun 26;14:1173842. doi: 10.3389/fmicb.2023.1173842. eCollection 2023.
8
Predicting the RSV Surge: Pediatric RSV Patterns of the COVID Pandemic.预测 RSV 高峰:COVID 大流行期间儿科 RSV 模式。
Pediatr Infect Dis J. 2023 Sep 1;42(9):e349-e351. doi: 10.1097/INF.0000000000003980. Epub 2023 May 24.
9
Impact of COVID-19 on the Changing Patterns of Respiratory Syncytial Virus Infections.新型冠状病毒肺炎对呼吸道合胞病毒感染变化模式的影响
Infect Dis Rep. 2022 Jul 24;14(4):558-568. doi: 10.3390/idr14040059.
10
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.